共 120 条
[1]
Bortfeld T(1996)An analytical approximation of depth-dose distributions for therapeutic proton beams Phys Med Biol 41 1331-1339
[2]
Schlegel W(2012)Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: subanalyses of a phase III trial J Hepatol 57 821-829
[3]
Bruix J(2007)Sorafenib (BAY 43-9006) inhibits tumor growth and vascularization and induces tumor apoptosis and hypoxia in RCC xenograft models Cancer Chemother Pharmacol 59 561-574
[4]
Raoul J-L(2009)Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial Lancet Oncol 10 25-34
[5]
Sherman M(2012)Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma according to baseline status: subset analyses of the phase III Sorafenib Asia-Pacific trial Eur J Cancer 48 1452-1465
[6]
Chang YS(2008)Transcatheter arterial chemoembolization for advanced hepatocellular carcinoma with inferior vena cava and right atrial tumors Cardiovasc Intervent Radiol 31 735-744
[7]
Adnane J(2014)Is there a role for proton therapy in the treatment of hepatocellular carcinoma? A systematic review Radiother Oncol 111 1-10
[8]
Trail PA(2015)Trans-arterial chemoembolization and external beam radiation therapy for treatment of hepatocellular carcinoma with a tumor thrombus in the inferior vena cava and right atrium Cancer Imaging 15 1-7
[9]
Cheng AL(2009)New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1) Eur J Cancer 45 228-247
[10]
Kang YK(2009)A prospective study of hypofractionated proton beam therapy for patients with hepatocellular carcinoma Int J Radiat Oncol Biol Phys 74 831-836